Albumin study in severe burn patients in ICU
Part of Injuries & trauma, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial looks at whether giving or measuring albumin (a blood protein) can help predict outcomes for people with very severe burns in the ICU. It may help doctors understand who is at higher risk and guide care during the first day after injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- Your burn area is more than 30% of your body surface
- You were admitted to the ICU within 12 hours after the burn
- You are not pregnant
- You are not in a situation where active life-sustaining treatment is limited when you arrive in the ICU
- You are 80 years old or younger
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This study looks at whether a simple blood test (called RDW/albumin ratio) can help predict the risk of death in patients with serious burn injuries. It aims to improve care and support for burn patients in the ICU.
This trial looks at how changes in prealbumin (a protein that shows your nutrition status) in the blood relate to how well patients recover in the ICU. It may help doctors better understand your prognosis.
This trial tests whether giving albumin (a blood protein through an IV) can improve recovery after acute kidney injury in people who are in the ICU and need kidney support treatment. It mainly aims to help the kidneys bounce back better after this serious illness.
This study tests whether certain blood tests can accurately detect sepsis in adults with burns. It might help doctors diagnose and treat sepsis faster in burn intensive care patients.
This trial tests if giving human albumin (a protein fluid) can help treat septic shock in surgical intensive care patients. If you have severe infection and very low blood pressure after surgery, this treatment might improve recovery.
Hear when a new Severe Burn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.